![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bbi Hldgs | LSE:BBI | London | Ordinary Share | GB00B00M4S16 | ORD 2.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 185.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:8861L BBI Holdings PLC 16 January 2008 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL FOR IMMEDIATE RELEASE 16 JANUARY 2008 RECOMMENDED CASH AND SHARE ACQUISITION by INVERNESS MEDICAL INNOVATIONS, INC. of BBI HOLDINGS PLC (TO BE EFFECTED BY MEANS OF A SCHEME OF ARRANGEMENT) Result of Court Meeting and General Meeting BBI Holdings plc ("BBI" or the "Company") announces that at the meeting convened by the court and held earlier today, 16 January 2008 (the "Court Meeting"), and at the subsequent General Meeting (the "GM") to approve the scheme of arrangement (the "Scheme") to implement the acquisition of the Company by Inverness Medical Innovations, Inc. (the "Acquisition"), all of the resolutions received the necessary majorities and were accordingly approved. Voting results The voting results in relation to the Court Meeting and the GM are summarised below: COURT MEETING Resolution to approve the Scheme: Number of BBI Shareholders: FOR: 223 AGAINST: 7 representing the following number of votes: FOR: 21,633,971 (99.99%) AGAINST: 5,238 (0.01%) GM The special resolution to give effect to the Scheme was passed unanimously on a show of hands at the GM. Completion of the Acquisition remains subject to the satisfaction or, if appropriate, waiver of the conditions to the Acquisition as set out in the Document in relation to the Scheme dated 21 December 2007 (the "Scheme Document") and sent to BBI Shareholders, including, inter alia, the sanction of the Scheme by the High Court. The expected timetable of principal events in connection with the Scheme is set out in the Appendix to this announcement. Enquiries: BBI Holdings Plc Inverness Medical Innovations, Inc. Tel: +44 (0) 2920 747232 Tel: +1 (781) 647 3900 David Evans, Chairman Doug Guarino Julian Baines, Chief Executive (Director of Corporate Relations) Cenkos Securities plc IDJ Limited (Financial adviser, nominated adviser and (Financial adviser to Inverness) broker to BBI Holdings Plc) Tel: +44 (0) 20 7397 8900 Tel: +44 (0) 20 7355 1200 Ian Soanes John Incledon Adrian Hargrave David Bolton The BBI Directors accept responsibility for the information contained in this Announcement. To the best of the knowledge and belief of the BBI Directors (who have taken all reasonable care to ensure that such is the case), the information contained in this Announcement is in accordance with the facts and does not omit anything likely to affect the import of such information. Cenkos, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for BBI and no one else in connection with the Proposal and the Scheme and will not be responsible to anyone other than BBI for providing the protections afforded to the clients of Cenkos nor for providing advice in relation to the Proposal and the Scheme or any other matter or arrangement referred to in this announcement. IDJ Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for Inverness and no one else in connection with the Proposal and the Scheme and will not be responsible to anyone other than Inverness for providing the protections afforded to the clients of IDJ Limited nor for providing advice in relation to the Proposal and the Scheme or any other matter or arrangement referred to in this announcement. The release, publication or distribution of this Announcement in jurisdictions other than the United Kingdom may be restricted by law and therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom should inform themselves about, and observe, any applicable requirements. This Announcement has been prepared for the purposes of complying with English law and the City Code and the information disclosed may not be the same as that which would have been disclosed if this Announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of England. This Announcement does not constitute an offer to sell or an invitation to purchase or subscribe for any securities or a solicitation of any vote or approval in any jurisdiction whether relating to the Proposal or otherwise. This Announcement does not constitute a prospectus or a prospectus equivalent document. The Proposal will be made solely through the Scheme Document which contains the full details, terms and conditions of the Proposal, including details of how to vote in respect of the Proposal. BBI Shareholders are advised to read the Scheme Document carefully once it has been received. The New Inverness Shares to be issued in connection with the Proposal have not been and will not be registered under, nor have the relevant clearances been, nor will they be, obtained from the Securities Commission of any province or territory of Canada, nor has any prospectus in relation to the New Inverness Shares been lodged with, or registered by, the Australian Securities & Investments Commission nor any securities authority in Japan. Accordingly, unless an exemption under the relevant securities law is available, the New Inverness Shares may not be offered, sold, re-sold or delivered, directly or indirectly, into or from Canada, Australia or Japan. NOTICE TO US SHAREHOLDERS For US securities law purposes, the exchange offer described in the Scheme Document will be made for the securities of a foreign company by means of a scheme of arrangement under Section 425 of the United Kingdom Companies Act 1985. The offer is subject to disclosure and procedural requirements of a foreign country that are different from those of the United States. Financial statements relating to BBI included or incorporated in the Scheme Document have been prepared in accordance with foreign accounting standards that may not be comparable to the financial statements of United States companies. It may be difficult for you to enforce your rights and any claim you may have arising under United States federal securities laws, since BBI is located in a foreign country, and some or all of its officers and directors may be residents of a foreign country. You may not be able to sue BBI or its officers or directors in a foreign court for violations of the U.S. securities laws. It may be difficult to compel BBI and its affiliates to subject themselves to a U.S. court's judgment. You should be aware that Inverness may purchase securities otherwise than pursuant to the Scheme, such as in open market or privately negotiated purchases. BBI is circulating the Scheme Document to its shareholders in connection with its solicitation of proxies in connection with the Scheme. The Scheme Document contains important information about BBI, Inverness, the Scheme and related matters. BBI shareholders are urged to read the Scheme Document carefully. Words and expressions defined in the Scheme Document shall, unless the context provides otherwise, have the same meanings in this Announcement. Appendix Expected timetable of principal events Event Time and/or date 1 Initial Court Hearing to provide directions in relation to the Scheme 10.30 am on 24 January 2008 Court Hearing to Sanction the Scheme 8 February 2008 1 Last day of dealings in, and registration of transfers of, and 6.00 pm on 8 February 2008 1 disablement in CREST of, BBI Shares Latest time for receipt of green Cash Election Form (2) 6.00 pm on 8 February 2008 Reorganisation Record Date 6.00 pm on 8 February 2008 1 Delisting of BBI Shares 7.00 am on 11 February 2008 1 Scheme Record Time 6.00 pm on 11 February 2008 1 Court Hearing to confirm the Capital reduction 11 February 2008 1 Scheme Effective Date 12 February 2008 1 Latest Date for despatch of certificates for New Inverness Shares and 26 February 2008 1 Cash Consideration due under the Scheme 1These dates are indicative only and will depend, inter alia, on the dates upon which the Conditions are either satisfied or waived (to the extent they are capable of being waived), and the dates upon which the Court sanctions the Scheme and confirms the associated reduction of capital and the Court Order sanctioning the Scheme and confirming the reduction of capital is delivered to the Registrar of Companies in England and Wales and, in respect of the reduction of capital, is registered by the Registrar of Companies in England and Wales. It may be necessary for more than one court hearing to sanction the Scheme. 2 At the request of the London Stock Exchange, the latest time and date for receipt of the green Cash Election Form has been extended from the time and date published in the Scheme Document. This information is provided by RNS The company news service from the London Stock Exchange END ROMILFILLLIRLIT
1 Year Bbi Holdings Chart |
1 Month Bbi Holdings Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions